glp-1 and crohn's Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases Obesity and/or Diabetes: A Target Trial Emulation Missed our Instagram Live on
Description
These have been widely tested and shown to be safe for this purpose
See if you are eligible today
Cardiovasc Diabetol 24 , 87 (2025)
For consumers, this means cost savings and more access
